1. Home
  2. OI vs PRCT Comparison

OI vs PRCT Comparison

Compare OI & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo O-I Glass Inc.

OI

O-I Glass Inc.

N/A

Current Price

$16.45

Market Cap

2.3B

ML Signal

N/A

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

N/A

Current Price

$27.25

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OI
PRCT
Founded
1903
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.8B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
OI
PRCT
Price
$16.45
$27.25
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$17.43
$51.13
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
02-10-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,455,000,000.00
$299,907,000.00
Revenue This Year
$1.39
$48.30
Revenue Next Year
$1.43
$29.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.07
52 Week Low
$9.23
$27.23
52 Week High
$16.69
$75.29

Technical Indicators

Market Signals
Indicator
OI
PRCT
Relative Strength Index (RSI) 66.41 32.26
Support Level $14.91 $28.76
Resistance Level $16.69 $29.94
Average True Range (ATR) 0.45 1.46
MACD 0.09 -0.23
Stochastic Oscillator 92.93 0.00

Price Performance

Historical Comparison
OI
PRCT

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: